Study to evaluate the clinical effectiveness of intermittent infusion hemodiafiltration (I-HDF)
Not Applicable
- Conditions
- Chronic Kidney Failure
- Registration Number
- JPRN-UMIN000015891
- Lead Sponsor
- I-HDF Multicenter Study Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 70
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with severe cardiovascular disease (NYHA class 3 or 4), hepatic failure, respiratory failure, or malignant tumor 2) 8% or more of the rate of weight gain 3) Patients who are judged ineligible by the attending physician.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SF-36 ver2 Clinical condition (VAS scale)
- Secondary Outcome Measures
Name Time Method Vital signs (blood pressure, pulse) Number of treatments by medical staff Blood test Dose of erythropoietin-stimulating agent Solute removal ability